
Tactiva Therapeutics
Developing next generation adoptive cell therapy strategies that deliver lethal hits to cancer cells.
Employees
Enterprise value
$140—210m
Authorizing premium user...
Developing next generation adoptive cell therapy strategies that deliver lethal hits to cancer cells.